Retatrutide's 24% weight loss in 48 weeks doesn't just exceed semaglutide's performanceit does so in a shorter timeframe, suggesting both superior efficacy and potentially faster onset of clinical benefits
While different salts of active pharmaceutical ingredients are frequently considered pharmaceutical alternatives by the FDA, there are currently no therapeutic equivalents to semaglutide listed in the FDA's Orange Book
Statistical analysis was performed using the GraphPad Prism software (version 6, GraphPad Software Inc., Boston, MA, USA)
Its ability to penetrate sanctuary sites such as the central nervous system and eyes further enhances its therapeutic potential (Hodges et al., 2024)
Moreover, emerging mechanistic and clinical evidence published in recent years has not yet been comprehensively integrated
PMID: 236 MilesDGligorovJAndrFCameronDSchneeweissABarriosCet al